Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

Phase 1

1(33.3%)

N/A

1(33.3%)

Phase 4

1(33.3%)

3Total

Phase 1(1)

N/A(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT07224087Phase 1Recruiting

Development of a MHBC Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients

Role: collaborator

NCT06132477Phase 4Recruiting

Impact GLP-1 Agonists Following Bariatric

Role: collaborator

NCT01213940Not ApplicableCompleted

Vascular Endothelium Changes After Bariatric Surgery (Endothelial Progenitor Cells)

Role: collaborator

NCT03331536Completed

Skeletal Health in Bariatric Surgery Patients

Role: collaborator

NCT00948545Completed

Autonomic Nervous System Function Following Bariatric Surgery

Role: collaborator

NCT01317147Completed

The Effect of Gastric Bypass on the Pharmacokinetics of Serotonin Reuptake Inhibitors

Role: collaborator

All 6 trials loaded